Christos Evangelou, PhD

Christos Evangelou, PhD, is a contributor for Blood Cancers Today.

Articles by Christos Evangelou, PhD

Christos Evangelou, PhDPrint | June 24, 2025
The advent of AI technologies such as machine learning has opened new avenues for predicting adverse drug reactions.
Read More